Related Experiment Videos
[Ischemic coronary artery disease in menopause]
Rivista Europea Per Le Scienze Mediche E Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Europeenne Pour Les Sciences Medicales Et Pharmacologiques
|June 1, 1989
Summary
Women experience less Coronary Artery Disease (CAD) but face obscured survival rates due to comorbidities like hypertension and diabetes. This review examines CAD in women, estrogen
Area of Science:
- Cardiology
- Women's Health
- Epidemiology
Context:
- Coronary Artery Disease (CAD) incidence and prognosis differ between sexes.
- Women often present with comorbidities like hypertension and diabetes, potentially confounding survival data.
- Existing research on estrogen's effect on CAD morbidity yields conflicting results.
Purpose:
- To examine the incidence, clinical presentation, and prognosis of Coronary Artery Disease (CAD) in women.
- To review the literature on estrogen use and its impact on CAD morbidity.
- To analyze "Syndrome X," characterized by angina with a normal coronary arteriogram.
Summary:
- Women generally have a lower incidence and better prognosis for Coronary Artery Disease (CAD) than men.
- However, higher rates of hypertension and diabetes, and older age in women can obscure survival advantages.
- The paper synthesizes information on CAD in women, estrogen's role, and Syndrome X.
Impact:
- Provides a comprehensive overview of CAD in the female population.
- Highlights factors influencing CAD presentation and outcomes in women.
- Clarifies the complex relationship between estrogen and cardiovascular health.